BURRELL INTERNATIONAL GROUP LLC

Lobbying for AMO PHARMA, LTD. · Biopharmaceutical research and development

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $50,000.00 income · posted Apr 17, 2026

Lobbying activity 1

Health Issues

Rare Disease Policy and FDA Policy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem